Erlotinib (Tarceva°) cancer du pancréas métastasé : Privilégier les soins palliatifs
- Other title
- Erlotinib for metastatic pancreas adenocarcinoma : palliative cares are better (en)
- Source
La Revue Prescrire. 2007, Vol 27, Num 289, pp 811-811, 1 p ; ref : 2 ref
- ISSN
- 0247-7750
- Scientific domain
- General medicine general surgery; Pharmacology drugs
- Publisher
- Association Mieux prescrire, Paris
- Publication country
- France
- Document type
- Article
- Language
- French
- Keyword (fr)
- Anticancéreux Cancer pancréas Erlotinib Fiche technique Homme Monographie Métastase Soins palliatifs Toxicité Traitement Inhibiteur de la tyrosine kinase Appareil digestif pathologie Enzyme Inhibiteur enzyme Pancréas pathologie Protein-tyrosine kinase Quinazoline dérivé Récepteur facteur croissance épiderme Transferases Tumeur maligne
- Keyword (en)
- Antineoplastic agent Pancreas cancer Erlotinib Technical card Human Monograph Metastasis Palliative care Toxicity Treatment Digestive diseases Enzyme Enzyme inhibitor Pancreatic disease Protein-tyrosine kinase Quinazoline derivatives Epidermal growth factor receptor Transferases Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del páncreas Erlotinib Ficha técnica Hombre Monografía Metástasis Cuidado paliativo Toxicidad Tratamiento Aparato digestivo patología Enzima Inhibidor enzima Páncreas patología Protein-tyrosine kinase Receptor factor crecimiento epidermi Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13C Liver. Biliary tract. Portal circulation. Exocrine pancreas / 002B13C01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19198023
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:3:\"289\";s:8:\"\u0000*\u0000spage\";s:3:\"811\";s:8:\"\u0000*\u0000epage\";s:3:\"811\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"1\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:3:\"289\";s:8:\"\u0000*\u0000spage\";s:3:\"811\";s:8:\"\u0000*\u0000epage\";s:3:\"811\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"1\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:3:\"289\";s:8:\"\u0000*\u0000spage\";s:3:\"811\";s:8:\"\u0000*\u0000epage\";s:3:\"811\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"1\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:3:\"289\";s:8:\"\u0000*\u0000spage\";s:3:\"811\";s:8:\"\u0000*\u0000epage\";s:3:\"811\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"1\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:3:\"289\";s:8:\"\u0000*\u0000spage\";s:3:\"811\";s:8:\"\u0000*\u0000epage\";s:3:\"811\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Erlotinib (Tarceva\u00b0) cancer du pancr\u00e9as m\u00e9tastas\u00e9 : Privil\u00e9gier les soins palliatifs\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"1\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
arXiv access
